Skip to main content
. 2021 Nov 15;16(11):e0260003. doi: 10.1371/journal.pone.0260003

Fig 2. Toxicity testing of 4 potential AMPs to human red blood cells (RBCs) and peripheral blood mononuclear cells (PBMCs).

Fig 2

Percent hemolysis of human RBCs after treatment with various concentrations of four AMPs for 1 h. (A). Percent PBMCs viability after treated with various concentrations of four AMPs for 1 h. (B). The data exhibited mean ± S.D. of duplicates from two independent experiments. One-way ANOVA followed by Tukey’s test was used to determine significant differences (*P <0.05). MIC of S61, S62, S63 and KLK1 were 6.25, 12.5, 9.38 and 37.5 μg/ml.